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Cedar Care Offers Monoclonal Antibody Treatment for COVID-19
CEDARVILLE, OHIO -- Cedar Care Village Pharmacy has been authorized by the Ohio Department of
Health to administer monoclonal antibody treatments for COVID-19. It is believed to be the first
community pharmacy in Ohio to administer the antibody treatment.
Cedar Care, the teaching pharmacy for Cedarville University's School of Pharmacy, has already begun
to administer the antibodies by appointment at its downtown Cedarville is open 9 a.m.-6 p.m. Monday
through Friday and 9 a.m.-1 p.m. Saturday. The pharmacy serves residents throughout northeastern
Greene County.
Monoclonal antibodies can be injected into at-risk patients to help them fight off COVID-19. According
to Justin Coby, director at Cedar Care, monoclonal antibodies are created when scientists isolate and
clone COVID-19 antibodies from people who have recovered from the disease. Cedar Care is focused on
administering the antibodies to patients age 65 or older and to those who are immunocompromised and
those who have already tested positive for COVID-19. These individuals can make an appointment for
treatment within 10 days of symptoms starting. .
Cedar Care will administer the monoclonal antibodies as an injection, and patients will be asked to stay
an hour after receiving the injection for monitoring by Cedar Care pharmacists for reactions. For the
whole process, patients should allow about 90 minutes, Coby suggested. Patients with Medicare will
have the costs of the injection covered.
Coby believes that the treatment will reduce the amount of people who need to be hospitalized with
COVID-19.
“We’re interested in helping our community because those individuals may not mount enough
antibodies to fight off an infection, especially if they have not been vaccinated,” Coby said.
It will also reduce health care costs, since treating patients with the antibodies in an outpatient
environment is less expensive than caring for patients in emergency rooms.
Cedar Care received 24 initial rounds of the Regeneron REGEN-COV monoclonal antibodies, which are
being distributed by the Ohio Department of Health, and may receive more if the pharmacy has high
demand.
“If anyone has just been diagnosed with COVID and is concerned, they can reach out to us here at Cedar
Care,” Coby said. “We can have a conversation about the opportunity to receive the monoclonal
antibodies.”
Located in southwest Ohio, Cedarville University is an accredited, Christ-centered, Baptist institution
with an enrollment of 4,715 undergraduate, graduate and online students in more than 150 areas of
study. Founded in 1887, Cedarville is one of the largest private universities in Ohio, recognized nationally

for its authentic Christian community, rigorous academic programs, including the Doctor of Pharmacy
program, strong graduation and retention rates, accredited professional and health science offerings
and high student engagement ranking. For more information about the University, visit cedarville.edu.
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